BioGaia has signed a new supply and license agreement with Nestlé for the inclusion of BioGaia’s patented Lactobacillus reuteri in a new category of products. This long-term agreement gives Nestlé exclusive rights to utilize this probiotic in an additional range of products in a large number of countries, with focus on emerging markets.
Lactobacillus reuteri will be added in an existing product line of Nestlé. This development has been greatly facilitated by the available clinical studies performed by BioGaia and represents a great opportunity to offer a differentiated and value-added solution to the consumers.
This is the third agreement with Nestlé after the sale of the perpetual license to use Lactobacillus reuteri in infant nutrition products to Nestlé in February 2012. It illustrates the good collaboration between the two companies with cooperation in both the scientific as well as the commercial fields.
“We are very pleased to having been able to conclude this agreement with Nestlé as it gradually replaces a significant part of the business that we earlier sold to them. It reflects the excellent partnership established”, says Peter Rothschild, president of BioGaia.